Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Language
Publication year range
1.
J Neurochem ; 145(3): 245-257, 2018 05.
Article in English | MEDLINE | ID: mdl-29315582

ABSTRACT

Peripheral myelin protein 22 (PMP22) is a component of compact myelin in the peripheral nervous system. The amount of PMP22 in myelin is tightly regulated, and PMP22 over or under-expression cause Charcot-Marie-Tooth 1A (CMT1A) and Hereditary Neuropathy with Pressure Palsies (HNPP). Despite the importance of PMP22, its function remains largely unknown. It was reported that PMP22 interacts with the ß4 subunit of the laminin receptor α6ß4 integrin, suggesting that α6ß4 integrin and laminins may contribute to the pathogenesis of CMT1A or HNPP. Here we asked if the lack of α6ß4 integrin in Schwann cells influences myelin stability in the HNPP mouse model. Our data indicate that PMP22 and ß4 integrin may not interact directly in myelinating Schwann cells, however, ablating ß4 integrin delays the formation of tomacula, a characteristic feature of HNPP. In contrast, ablation of integrin ß4 worsens nerve conduction velocities and non-compact myelin organization in HNPP animals. This study demonstrates that indirect interactions between an extracellular matrix receptor and a myelin protein influence the stability and function of myelinated fibers.


Subject(s)
Arthrogryposis/metabolism , Hereditary Sensory and Motor Neuropathy/metabolism , Integrin alpha6beta4/metabolism , Schwann Cells/metabolism , Animals , Arthrogryposis/pathology , Hereditary Sensory and Motor Neuropathy/pathology , Mice , Mice, Knockout , Myelin Proteins/metabolism , Myelin Sheath/metabolism , Myelin Sheath/pathology , Schwann Cells/pathology
SELECTION OF CITATIONS
SEARCH DETAIL